Neurotrope Shareholders to Own 49 Percent of Petros Under Revised Merger Agreement with MetuchenPRNewsWire • 09/30/20
Neurotrope and Metuchen Pharmaceuticals Announce Merger Agreement to Form Petros Pharmaceuticals, a Men's Health CompanyPRNewsWire • 05/18/20
Neurotrope's stock plummets on heavy volume after disappointing trial of Alzheimer's treatmentMarket Watch • 09/09/19
Is the Options Market Predicting a Spike in Neurotrope (NTRP) Stock?Zacks Investment Research • 08/21/19
Two Very Speculative Biotechs With Promising Alzheimer’s Treatment Hopefuls24/7 Wall Street • 06/18/19